Positive Clinical Advancements Reinforce Buy Rating for …
Jun 20, 2024 · With a pivotal trial for RGX-202 anticipated to commence between late 2024 and early 2025, Yi Chen sees these developments as substantial grounds for the Buy rating and maintains a $38 price ...
OFF
Positive Clinical Advancements Reinforce Buy Rating For …
2 weeks from now
Jun 20, 2024 · With a pivotal trial for RGX-202 anticipated to commence between late 2024 and early 2025, Yi Chen sees these developments as substantial grounds for the Buy rating and maintains a $38 price ...
businessinsider.com
OFF
Maxim Group Reaffirms Buy Rating For Lucid Diagnostics Amidst …
2 weeks from now
Jun 29, 2024 · Maxim Group's Anthony Vendetti affirmed a Buy rating on Lucid Diagnostics, maintaining a $4.00 price target. The decision is based on Lucid's Q1 2024 revenue meeting …
longportapp.com
OFF
Sutro Biopharma Retains Stock Target With Buy Rating On Key ...
2 weeks from now
Oct 11, 2024 · Despite the positive outlook from H.C. Wainwright, the company's stock has experienced significant pressure, with a 28.2% decline over the past month and an 8.31% …
investing.com
OFF
2 'Strong Buy' Biotech Stocks With 120% Or More Upside Potential …
2 weeks from now
The pre-revenue company reported asmaller-than-expected loss of $0.22 per share, which marks a slight improvement from the year-ago quarter’s $0.23 loss per share.During the quarter, the …
msn.com
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension